Researcher

Lida Du

Provincial Laboratory of Polymorphic Drugs, Shandong, China; Institute of Molecular Medicine & Innovative Pharmaceutics, Qingdao University, Qingdao, China. Electronic address: duld1990@gmail.com.

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

Latest

Everything in the corpus, newest first.

MAY 28, 2026 · JOURNAL ARTICLE

Isoquercetin-ligustrazine co-polymorph attenuates hypoxia-accelerated Alzheimer's disease by suppressing PERK-CHOP-mediated ER stress.

Experimental Neurology

Preclinical study in transgenic mice demonstrating mechanism of a novel compound on hypoxia-accelerated AD pathology, without clinical translation or comparative efficacy data.

PreliminaryRongjing Shen Alzheimer Disease Yifei Xu

Reported

Hypoxia exposure durationfour weeks